`Patent Owner’s Mandatory Notices
`
`
`
`
`
`
`
`
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`_________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`
`
`
`FRESENIUS KABI USA, LLC
`Petitioner
`
`v.
`
`CEPHALON, INC.
`Patent Owner
`
`_____________
`
`Case IPR2016-00111
`Patent No. 8,895,756
`
`_____________________
`
`PATENT OWNER’S MANDATORY NOTICES
`PURSUANT TO 37 C.F.R. § 42.8
`
`
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`United States Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`
`
`
`
`IPR2016-00111
`Patent Owner’s Mandatory Notices
`
`
`
`
`Pursuant to 37 C.F.R. § 42.8, Patent Owner, Cephalon, Inc. (“Cephalon”),
`
`hereby submits the following mandatory notices.
`
`I.
`
`
`
`REAL PARTY IN INTEREST (37 C.F.R. § 42.8(b)(1))
`
`Cephalon is the patent owner and real party-in-interest. Cephalon is an
`
`indirect wholly owned subsidiary of Teva Pharmaceuticals Industries Ltd.
`
`II. RELATED MATTERS (37 C.F.R. § 42.8(b)(2))
`
`A.
`
`Judicial Matters
`
`U.S. Patent No. 8,895,756 (“’756 Patent”) has been or is currently at issue in
`
`the following district court litigation:
`
` Cephalon, Inc. v. Hetero Labs Ltd., No. 1:13-cv-02046-GMS (D.
`
`Del.), consolidated into In re Bendamustine Consol. Cases, No. 1:13-
`
`cv-02046-GMS (D. Del.);
`
` Cephalon, Inc. v. Pharmasci. Inc., 1-14-cv-00568-GMS (D. Del.),
`
`consolidated into In re Bendamustine Consol. Cases, No. 1:13-cv-
`
`02046-GMS (D. Del.)
`
` Cephalon, Inc. v. Nang Kuang Pharm. Co., Ltd., No. 1:14-cv-05180-
`
`KAM-RER (E.D.N.Y.);
`
`
`
`1
`
`
`
`
`
`IPR2016-00111
`Patent Owner’s Mandatory Notices
`
`
`
` Cephalon Inc. v. Sandoz Inc., No. 1:15-cv-00178-GMS (D. Del.),
`
`consolidated into In re Bendamustine Consol. Cases, No. 1:13-cv-
`
`02046-GMS (D. Del.);
`
` Cephalon, Inc. v. Dr. Reddy’s Labs., Ltd., No. 1:15-cv-00179-GMS
`
`(D. Del.), consolidated into In re Bendamustine Consol. Cases, No.
`
`1:13-cv-02046-GMS (D. Del.);
`
` Cephalon, Inc. v. Apotex, Inc., No. 1:15-cv-00404-GMS (D. Del.);
`
`and
`
` Cephalon, Inc. v. Panacea Biotec, Ltd., No. 1:15-cv-00735-GMS (D.
`
`Del.).
`
`B. Administrative
`
`The ’756 Patent claims priority to U.S. Patent No. 8,436,190, which is
`
`currently under review in IPR2015-00503.
`
`
`
`The ’756 Patent and U.S. Patent No. 8,791,270 (“’270 Patent”) both claim
`
`priority to U.S. Provisional Patent Application No. 60/644,354. The ’270 Patent is
`
`the subject of petitions for Inter Partes Review in IPR2016-00026 and IPR2016-
`
`00098. The Board has not yet decided whether to institute review on these
`
`petitions.
`
`
`
`
`
`2
`
`
`
`
`
`IPR2016-00111
`Patent Owner’s Mandatory Notices
`
`
`
`Pending U.S. Patent Application No 14/845,564 claims the benefit of the
`
`’756 Patent.
`
`III. LEAD AND BACKUP COUNSEL (37 C.F.R. § 42.8(b)(3))
`
`LEAD COUNSEL
`
`BACK-UP COUNSEL
`
`Soumitra (Sam) Deka
`
`(Reg. No. 70,252)
`
`Aaron Stiefel
`
`(Pro Hac Vice)
`
`KAYE SCHOLER LLP
`
`KAYE SCHOLER LLP
`
`Two Palo Alto Square
`
`250 West 55th Street
`
`3000 El Camino Real, Suite 400
`
`New York, NY 10019-9710
`
`Palo Alto, CA 94306
`
`Tel: (212) 836-8000
`
`Fax: (212) 836-8689
`
`soumitra.deka@kayescholer.com
`
`
`
`Tel: (212) 836-8000
`
`Fax: (212) 836-8689
`
`aaron.stiefel@kayescholer.com
`
`IV. SERVICE INFORMATION (37 C.F.R. § 42.8(b)(4))
`
`Please direct all correspondence to counsel at the contact information above.
`
`Petitioner consents to service by electronic mail at
`
`soumitra.deka@kayescholer.com and aaron.stiefel@kayescholer.com.
`
`
`
`
`
`3
`
`
`
`
`
`IPR2016-00111
`Patent Owner’s Mandatory Notices
`
`Respectfully Submitted,
`KAYE SCHOLER LLP
`
`
`
`/s/ Soumitra Deka
`
`
`
`
`Soumitra (Sam) Deka
`(Reg. No. 70,252)
`Two Palo Alto Square
`3000 El Camino Real, Suite 400
`Palo Alto, CA 94306
`Tel: (212) 836-8000
`Fax: (212) 836-8689
`
`Attorneys for Patent Owner
`
`4
`
`
`
`
`
`
`
`Dated: November 23, 2015
`
`
`
`
`
`
`
`
`
`
`IPR2016-00111
`Patent Owner’s Mandatory Notices
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing document,
`
`PATENT OWNER’S MANDATORY NOTICES PURSUANT TO 37 C.F.R.
`
`§ 42.8, was served via electronic mail and by FedEx on November 23, 2015 to the
`
`following counsel of record for the Petitioner:
`
`
`
`
`
`
`
`
`
`
`
`/s/ Soumitra Deka
`Soumitra (Sam) Deka
`(Reg. No. 70,252)
`KAYE SCHOLER LLP
`
`
`
`
`
`Lawrence Sung
`Neal Seth
`WILEY REIN LLP
`nseth@wileyrein.com
`lsung@wileyrein.com
`
`WILEY REIN LLP
`ATTN: Patent Administration
`1776 K Street NW
`Washington, DC 20006
`
`Dated: November 23, 2015
`
`
`
`
`
`
`
`5
`
`